New drug aims to combat muscle loss in GLP-1 patients
A new investigational drug called apitegromab is being explored to preserve muscle mass in adults receiving glucagon-like peptide‑1 (GLP‑1) receptor agonists for obesity. The BBC has reported on a Nature Medicine study